Patent · US Active

Implantable nanochannel delivery devices

US11590072B2 · kind B2 · utility

0Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2020
Grant dateFeb 28, 2023
Priority date
Expiry dateMay 21, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M5/14276
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.